Zynerba Pharmaceuticals, Inc. short interest in 2021
In 2021, Zynerba Pharmaceuticals, Inc.'s disclosed short interest ran from 14.14% of shares outstanding on 15 Jan 2021 to 7.61% on 31 Dec 2021, a change of -6.53 percentage points. The year's high was 14.14% on 15 Jan 2021 and its low 4.43% on 13 Aug 2021, averaging 7.04% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.07 days on 31 Dec 2021. Full history: Zynerba Pharmaceuticals, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2021 in figures
- Start of year
- 14.14% (15 Jan 2021)
- End of year
- 7.61% (31 Dec 2021)
- Change
- -6.53 pp
- High
- 14.14% (15 Jan 2021)
- Low
- 4.43% (13 Aug 2021)
- Average
- 7.04%
- Highest days to cover
- 5.07 (31 Dec 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 14.14% | 3.60 | |
| 29 Jan 2021 | 14.02% | 3.00 | |
| 12 Feb 2021 | 10.87% | 1.00 | |
| 26 Feb 2021 | 10.17% | 1.00 | |
| 15 Mar 2021 | 7.97% | 1.91 | 10-K filed, results (8-K) |
| 31 Mar 2021 | 6.08% | 1.42 | |
| 15 Apr 2021 | 5.63% | 1.94 | |
| 30 Apr 2021 | 8.47% | 2.81 | |
| 14 May 2021 | 8.76% | 2.14 | 10-Q filed, results (8-K) |
| 28 May 2021 | 5.65% | 1.66 | |
| 15 Jun 2021 | 6.32% | 1.55 | |
| 30 Jun 2021 | 5.41% | 2.18 | |
| 15 Jul 2021 | 5.00% | 4.01 | |
| 30 Jul 2021 | 4.85% | 3.51 | |
| 13 Aug 2021 | 4.43% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 4.48% | 1.00 | |
| 15 Sep 2021 | 4.63% | 1.05 | |
| 30 Sep 2021 | 4.55% | 1.24 | |
| 15 Oct 2021 | 4.97% | 2.21 | |
| 29 Oct 2021 | 5.65% | 1.30 | |
| 15 Nov 2021 | 5.78% | 1.10 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 6.34% | 1.59 | |
| 15 Dec 2021 | 7.28% | 4.79 | |
| 31 Dec 2021 | 7.61% | 5.07 |
See also: Zynerba Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.